Tag Archives: announces

Vertex Announces U.S. FDA Approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations

BOSTON–(BUSINESS WIRE)–Jun. 9, 2021– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved expanded use of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis (CF) ages 6 through 11 years who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a… Read More »

Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease

May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »

Confirmit announces intention to merge with FocusVision

London, UK, Oslo, Norway and New York, NY, 7th January 2021 – Confirmit, a leading provider of solutions that enable Market Research, Customer Experience and Employee Engagement teams to turn insights into stories that fuel action, announced today its intention to merge with FocusVision, a leading provider of customer insights technology. The merger is conditioned… Read More »

Rajant Announces Michael Griffin, Lisa Porter, and Daniel Verwiel As Strategic Advisors to Support Technology and Market Direction

Former Leadership of US Dept of Defense Research & Engineering and Northrop Grumman Consulting on Future Opportunities Malvern, PA – October 13, 2020: Rajant Corporation, the provider of Kinetic Mesh® wireless networks, announces that Michael Griffin, Lisa Porter, and Daniel Verwiel will be strategic advisors and provide consultancy regarding Rajant’s future technology and market opportunities.… Read More »